Lyell Immunopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. 

CEO
Lynn Seely
CEOLynn Seely
Employees
161
Employees161
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
161
Employees161

LYEL Key Statistics

Market cap
554.71M
Market cap554.71M
Price-Earnings ratio
-1.64
Price-Earnings ratio-1.64
Dividend yield
Dividend yield
Average volume
107.13K
Average volume107.13K
High today
$24.99
High today$24.99
Low today
$23.33
Low today$23.33
Open price
$24.92
Open price$24.92
Volume
76.26K
Volume76.26K
52 Week high
$45.00
52 Week high$45.00
52 Week low
$7.65
52 Week low$7.65

Stock Snapshot

With a market cap of 554.71M, Lyell Immunopharma(LYEL) trades at $23.91. The stock has a price-to-earnings ratio of -1.64.

On 2026-04-21, Lyell Immunopharma(LYEL) stock traded between a low of $23.33 and a high of $24.99. Shares are currently priced at $23.91, which is +2.5% above the low and -4.3% below the high.

Lyell Immunopharma(LYEL) shares are trading with a volume of 76.26K, against a daily average of 107.13K.

During the past year, Lyell Immunopharma(LYEL) stock moved between $7.65 at its lowest and $45.00 at its peak.

During the past year, Lyell Immunopharma(LYEL) stock moved between $7.65 at its lowest and $45.00 at its peak.

LYEL News

TipRanks 7d
Lyell Immunopharma: Differentiated Cell Therapy Platform and Strong Leadership Underpin Buy Rating

In a report released today, Gil Blum from Needham maintained a Buy rating on Lyell Immunopharma, with a price target of $44.00. Unlock hedge fund-level data an...

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.